Work

Supplementary Figure S2 from Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer

Year: 2024
Type: supplementary-materials
Abstract: Supplementary Figure S2: Efficacy outcomes with adagrasib monotherapy in previously treated patients with KRASG12C-mutated unresecable or metastatic CRC.
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4401282981
Cites:
Cited by:
Related to: 10